The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-chloro-5-nitro-N-(4-sulfamoylphenylcarbamothioyl)benzamide ID: ALA2298025
PubChem CID: 72194625
Max Phase: Preclinical
Molecular Formula: C14H11ClN4O5S2
Molecular Weight: 414.85
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1ccc(NC(=S)NC(=O)c2cc([N+](=O)[O-])ccc2Cl)cc1
Standard InChI: InChI=1S/C14H11ClN4O5S2/c15-12-6-3-9(19(21)22)7-11(12)13(20)18-14(25)17-8-1-4-10(5-2-8)26(16,23)24/h1-7H,(H2,16,23,24)(H2,17,18,20,25)
Standard InChI Key: KZTQXHJTRKKEEJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
32.4510 -13.2855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4498 -14.1050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1579 -14.5140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8675 -14.1046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8647 -13.2819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1561 -12.8766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5709 -12.8707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2801 -13.2766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5678 -12.0535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9863 -12.8653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6955 -13.2712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9832 -12.0481 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.4017 -12.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1069 -13.2677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8126 -12.8571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8100 -12.0390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0958 -11.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3930 -12.0462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5156 -11.6268 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
40.2254 -12.0318 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.1014 -10.9165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.9186 -10.9165 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.1537 -12.0595 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.1597 -15.3358 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8673 -15.7445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4519 -15.7442 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 1 0
10 12 2 0
11 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
19 21 2 0
19 22 2 0
6 23 1 0
24 25 2 0
24 26 1 0
3 24 1 0
M CHG 2 24 1 26 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 414.85Molecular Weight (Monoisotopic): 413.9859AlogP: 2.02#Rotatable Bonds: 4Polar Surface Area: 144.43Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.88CX Basic pKa: ┄CX LogP: 2.76CX LogD: 2.76Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.39Np Likeness Score: -2.54
References 1. Saeed A, Zaib S, Pervez A, Mumtaz A, Shahid M, Iqbal J. (2013) Synthesis, molecular docking studies, and in vitro screening of sulfanilamide-thiourea hybrids as antimicrobial and urease inhibitors, 22 (8): [10.1007/s00044-012-0376-4 ]